BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  IRIDEX Announces First Quarter 2020 Financial Results

  IRIDEX Corporation reported financial results for the first quarter ended March 28, 2020.

  May 11, 2020

   · 

  7 min read
• Business

  American Renal Associates Holdings, Inc. Announces First Quarter 2020 Results

  Company Provides Update on COVID-19 Pandemic and Updates 2020 Outlook for Adjusted EBITDA-NCI

  May 11, 2020

   · 

  18 min read
• Pharm Country

  Nephros, Inc. to Hold Virtual Annual Meeting of Stockholders

  Nephros, Inc. announced that, due to the public health concerns associated with the ongoing coronavirus outbreak and to support the health and well-being of its stockholders, employees, and other partners, the location of the 2020 Annual Meeting of Stockholders of Nephros, Inc. has been changed.

  May 11, 2020

   · 

  3 min read
• Genetown

  LogicBio Therapeutics to Present New Data on GeneRide™ Platform and Next Generation Capsid Development Program at the American Society of Gene & Cell Therapy 2020 Annual Meeting

  Presentations Highlighting Novel Preclinical Methylmalonic Acidemia Model

  May 11, 2020

   · 

  3 min read
• Business

  DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs

  DURECT Corporation announced financial results for the three months ended March 31, 2020 and provided a corporate update.

  May 11, 2020

   · 

  11 min read
• Business

  CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business UpdateConference Call Scheduled for Today at 4:30 p.m. Eastern Time

  CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced financial results for the first quarter ended March 31, 2020 and provided an update on recent business events.

  May 11, 2020

   · 

  9 min read
• Biotech Bay

  VIVA Physicians Publishes Analysis Evaluating Mortality and Paclitaxel-Coated Devices

  The results of VIVA Physicians’ individual patient-level data analysis of the safety of paclitaxel-containing devices has been published in Circulation.

  May 11, 2020

   · 

  2 min read
• BioMidwest

  Vibativ® Sustained Potency Confirmed In Two Surveillance Studies

  Cumberland Pharmaceuticals Inc., a U.S. specialty pharmaceutical company announces two new publications detailing the sustained in vitro potency of Vibativ® as part of a 7-year antimicrobial surveillance program.

  May 11, 2020

   · 

  6 min read
• Deals

  Arcus Biosciences Announces New Employment Inducement Grants - May 11, 2020

  Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted three new employees options to purchase a total of 56,000 shares of the Company’s common stock at an exercise price per share of $30.08, which was the closing price on May 8, 2020.

  May 11, 2020

   · 

  1 min read
• Business

  Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments

  STRO-002 Encouraging Interim Phase 1 Clinical Data from an Ongoing Dose Escalation Study in Ovarian Cancer Presented at the AACR Virtual Meeting

  May 11, 2020

   · 

  14 min read